Trials / Sponsors / Regimmune Corporation
Regimmune Corporation
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | RGI-2001 for the Prevention of Acute Graft-vs-Host Disease in Subjects Following Allogeneic Hematopoietic Stem Graft Vs Host Disease, Graft-versus-host-disease, Acute-graft-versus-host Disease | Phase 2 | 2019-11-25 |
| Completed | Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation Graft Versus Host Disease | Phase 1 / Phase 2 | 2011-09-01 |